New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 15, 2012
10:06 EDTCF, KO, WFC, CBS, TZOO, PGR, HAS, HRS, CELG, BAM, BMCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: BMC Software (BMC) downgraded to Market Perform from Outperform at Raymond James... Brookfield (BAM) downgraded to Hold from Buy at Canaccord... Celgene (CELG) downgraded to Perform from Outperform at Oppenheimer... Harris (HRS) downgraded to Sell from Neutral at Lazard Capital... Hasbro (HAS) downgraded to Sell from Neutral at Goldman... Progressive (PGR) downgraded to Sell from Neutral at Citigroup... Travelzoo (TZOO) downgraded to Neutral from Buy at Ascendiant Capital... CBS (CBS) downgraded o Neutral from Overweight at Atlantic Equities... Wells Fargo (WFC) downgraded to Neutral from Market Perform at Leerink... Coca-Cola (KO) downgraded to Underperform from Outperform at CLSA... CF Industries (CF) downgraded to Hold from Buy at Dahlman Rose.
News For BMC;BAM;CELG;HRS;HAS;PGR;TZOO;CBS;WFC;KO;CF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
October 10, 2014
08:41 EDTCELGCelgene reports apremilast significantly improved preexisting psoriasis in study
Subscribe for More Information
08:39 EDTCELGCelgene says data show Apremilast treatment resulted in improved quality of life
Subscribe for More Information
06:44 EDTWFCWells Fargo to pay $5M to settle discrimination allegations
Subscribe for More Information
October 9, 2014
11:22 EDTWFCWells Fargo October volatility increases into Q3 and guidance
Subscribe for More Information
10:38 EDTKOPepsiCo climbs after results beat estimates, outlook raised
Subscribe for More Information
09:06 EDTHASDiscovery obtains exclusive TV rights to Hasbro film
Discovery's (DISCA) Family Channel - formerly Hub Network - has obtained the exclusive broadcast rights to Hasbro's (HAS) animated film "My Little Pony Equestria Girls: Rainbow Rocks" to air on October 17.
October 8, 2014
11:10 EDTCFOptions with increasing implied volatility
Subscribe for More Information
07:20 EDTWFCCapital Link to hold a forum
Subscribe for More Information
07:13 EDTWFCBank dealers agree to revised derivatives rules, FT reports
Subscribe for More Information
07:11 EDTCELGEuropean Academy of Dermatology and Venereology to hold a conference
23rd EADV Congress is being held in Amsterdam, The Netherlands on October 8-12.
06:56 EDTWFCBarclays lists several Large-Cap banks with the most Q3 upside
Subscribe for More Information
October 7, 2014
13:34 EDTBAMBrookfield receives court approval to buy bankrupt Revel casino, Reuters says
Subscribe for More Information
09:03 EDTCFCF Industries volatility elevated into Yara CEO resigns amid CF merger talks
CF Industries (CF) overall option implied volatility of 34 is above its 26-week average of 25 according to Track Data, suggesting large price movement into Yara (YARIY) announcing its CEO resigned amid CF merger talks.
08:13 EDTCFYara likely to buy CF for up to 30% premium, says Bernstein
Bernstein believes the potential merger between Yara (YARIY) and CF Industries (CF) will be structured as Yara buying CF with 75% stock, 25% cash and up to a 30% premium or $360 per share. The firm sees limited upside for Yara shareholders and keeps an Underperform rating on the stock. This morning, the company announced the resignation of its CEO and said merger talks with CF continue.
08:05 EDTCBSCBS risk/reward attractive at current levels, says FBR Capital
FBR Capital believes weaker September quarter TV trends and downward estimate revisions have pushed CBS shares into "value territory." The firm views the current risk/reward on shares as attractive and keeps an Outperform rating on CBS with a reduced price target of $71.
07:31 EDTCELGCelgene to present long-term efficacy and safety data on oral Otezla
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, announced that the latest research findings on OTEZLA, the company’s oral, selective inhibitor of phosphodiesterase 4, in plaque psoriasis and psoriatic arthritis will be presented at the 23rd European Academy of Dermatology and Venereology Congress in Amsterdam, October 8 – 12. In total, 11 abstracts will be presented at the meeting. OTEZLA data to be presented include long-term results from Celgene’s pivotal trial, ESTEEM 2 and pooled analyses of safety and tolerability results from the ESTEEM 1 and 2 studies in patients with moderate to severe plaque psoriasis. Additional analyses will evaluate the effect of OTEZLA on pruritus, difficult-to-treat areas such as nail and scalp, and palmoplantar psoriasis, work productivity and improvements in health-related quality of life. An analysis of long-term results from the PALACE clinical trial program evaluating OTEZLA in patients with active psoriatic arthritis will also be presented at the meeting. The analysis assesses the effect of OTEZLA treatment through 52 weeks on the signs and symptoms of psoriatic arthritis, including enthesitis and dactylitis in patients with pre-existing enthesitis or dactylitis.
07:24 EDTCELGAlliance for Regenerative Medicine
Subscribe for More Information
06:51 EDTWFCJustice Department set to attack more large banks by year end, NY Times says
Subscribe for More Information
06:31 EDTCFYara International CEO resigns amid CF merger talks
Yara International (YARIY) announced that Torgeir Kvidal has been appointed acting CEO effective today, and Jørgen Ole Haslestad has resigned as CEO. "Yara's Board have concluded that Haslestad is not the right person to lead the company going forward, also in light of the on-going talks with CF Industries (CF). Haslestad would not have a role in a potential merged company," says Leif Teksum, Chairman of the Yara Board of Directors. "The discussions with CF Industries will continue with Kvidal leading the Yara team, with support from the Board and in particular from me as Chairman," says Teksum. Kvidal has served as CFO since May 2012.
05:31 EDTHASHasbro signs global licensing agreement with PEZ
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use